Real-world impact of mepolizumab in patients with life-threatening asthma: US insurance claims database analysis-Reference-Cited by-同舟云学术

Real-world impact of mepolizumab in patients with life-threatening asthma: US insurance claims database analysis

Published:2021-12 Issue:12 Volume:43 Page:2064-2073
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Silver Jared^ORCID,Molfino Nestor,Bogart Michael,Packnett Elizabeth R.,McMorrow Donna,Wu Juan,Hahn Beth^ORCID

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014

2. Global Initiative for Asthma (GINA). 2021 GINA Report, Global Strategy for Asthma Management and Prevention [GINA website]. Vol 2020 2020. Available at: https://ginasthma.org/gina-reports.

3. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA;Suruki;BMC Pulm Med,2017

4. Asthma progression and mortality: the role of inhaled corticosteroids;O'Byrne;Eur Respir J,2019

5. British Thoracic Society Difficult Asthma Network. Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry;Heaney;Thorax,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness of Mepolizumab in Patients with Allergic and Non-Allergic Asthma;Journal of Asthma and Allergy;2024-03

2. Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review;Cureus;2023-12-01

3. Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study;Allergology International;2023-10

4. Real‐world effectiveness of mepolizumab in severe asthma and chronic rhinosinusitis in the United States: Impact of comorbidity and sinus surgery;International Forum of Allergy & Rhinology;2023-07-20

5. Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy;Allergology International;2023-01